Literature DB >> 15117576

Alarms based on real-time sensor glucose values alert patients to hypo- and hyperglycemia: the guardian continuous monitoring system.

Bruce Bode1, Kenneth Gross, Nancy Rikalo, Sherwyn Schwartz, Timothy Wahl, Casey Page, Todd Gross, John Mastrototaro.   

Abstract

The purposes of this study were to demonstrate the accuracy and effectiveness of the Guardian Continuous Monitoring System (Medtronic MiniMed, Northridge, California) and to demonstrate that the application of real-time alarms to continuous monitoring alerts users to hypo and hyperglycemia and reduces excursions in people with diabetes. A total of 71 subjects with type 1 diabetes, mean hemoglobin A1c of 7.6 +/- 1.1%, age 44.0 +/- 11.4 years, and duration of diabetes 23.6 +/- 10.6 years were enrolled in this two-period, randomized, multicenter study. Subjects were randomized into either an Alert group or a Control group. The accuracy of the Guardian was evaluated by treating the study data as a single-sample correlational design. Effectiveness of the Guardian alerts was evaluated by comparing the Alert group with the Control group. The mean (median) absolute relative error between home blood glucose meter readings and sensor values was 21.3% (17.3%), and the Guardian, on average, read 12.8 mg/dL below the concurrent home blood glucose meter readings. The hypoglycemia alert was able to distinguished glucose values < or =70 mg/dL with 67% sensitivity, 90% specificity, and 47% false alerts. The hyperglycemia alert showed a similar ability to detect sensor values > or =250 mg/dL with 63% sensitivity, 97% specificity, and 19% false alerts. The Alert group demonstrated a median decrease in the duration of hypoglycemic excursions (-27.8 min) that was significantly greater than the median decrease in the duration of hypoglycemic excursions in the Control group (-4.5 min) (P = 0.03). A marginally significant increase in the frequency of hyperglycemic excursions (P = 0.07) between Period 1 and Period 2 was accompanied by a decrease of 9.6 min in the duration of hyperglycemic excursions in the Alert group. Glucose measurements differ between blood samples taken from the finger and interstitial fluid, especially when levels are changing rapidly; however, these results demonstrate that the Guardian is reasonably accurate while performing continuous glucose monitoring. The subjects' responses to hypoglycemia alerts resulted in a significant reduction in the duration of hypoglycemic excursions; however, overtreating hypoglycemia may have resulted in a marginally significant increase in the frequency of hyperglycemic excursions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15117576     DOI: 10.1089/152091504773731285

Source DB:  PubMed          Journal:  Diabetes Technol Ther        ISSN: 1520-9156            Impact factor:   6.118


  55 in total

1.  Hypoglycemia prevention via pump attenuation and red-yellow-green "traffic" lights using continuous glucose monitoring and insulin pump data.

Authors:  Colleen S Hughes; Stephen D Patek; Marc D Breton; Boris P Kovatchev
Journal:  J Diabetes Sci Technol       Date:  2010-09-01

2.  Real-time glucose estimation algorithm for continuous glucose monitoring using autoregressive models.

Authors:  Yenny Leal; Winston Garcia-Gabin; Jorge Bondia; Eduardo Esteve; Wifredo Ricart; Jose-Manuel Fernández-Real; Josep Vehí
Journal:  J Diabetes Sci Technol       Date:  2010-03-01

3.  Effect of short-term use of a continuous glucose monitoring system with a real-time glucose display and a low glucose alarm on incidence and duration of hypoglycemia in a home setting in type 1 diabetes mellitus.

Authors:  Raymond J Davey; Timothy W Jones; Paul A Fournier
Journal:  J Diabetes Sci Technol       Date:  2010-11-01

Review 4.  A tale of two compartments: interstitial versus blood glucose monitoring.

Authors:  Eda Cengiz; William V Tamborlane
Journal:  Diabetes Technol Ther       Date:  2009-06       Impact factor: 6.118

5.  Continuous glucose monitoring in non-insulin-using individuals with type 2 diabetes: acceptability, feasibility, and teaching opportunities.

Authors:  Nancy A Allen; James A Fain; Barry Braun; Stuart R Chipkin
Journal:  Diabetes Technol Ther       Date:  2009-03       Impact factor: 6.118

6.  Real-time continuous glucose monitoring in the clinical setting: the good, the bad, and the practical.

Authors:  Irene Mamkin; Svetlana Ten; Sonal Bhandari; Neesha Ramchandani
Journal:  J Diabetes Sci Technol       Date:  2008-09

7.  Accuracy performance of the Medtronic NexSensor™ for 6 days in an inpatient setting using abdomen and buttocks insertion sites.

Authors:  Tim Peoples; Timothy Bailey; Brazg Ronald; Howard C Zisser; Bob Janowski; Suiying Huang; Cary Talbot; Qingqing Yang
Journal:  J Diabetes Sci Technol       Date:  2011-03-01

Review 8.  Delays in minimally invasive continuous glucose monitoring devices: a review of current technology.

Authors:  D Barry Keenan; John J Mastrototaro; Gayane Voskanyan; Garry M Steil
Journal:  J Diabetes Sci Technol       Date:  2009-09-01

9.  Combined insulin pump therapy with real-time continuous glucose monitoring significantly improves glycemic control compared to multiple daily injection therapy in pump naïve patients with type 1 diabetes; single center pilot study experience.

Authors:  Scott W Lee; Tom Sweeney; Debbie Clausen; Celia Kolbach; Allen Hassen; Anthony Firek; Charles Brinegar; Jerrold Petrofsky
Journal:  J Diabetes Sci Technol       Date:  2007-05

10.  The accuracy of the Guardian RT continuous glucose monitor in children with type 1 diabetes.

Authors: 
Journal:  Diabetes Technol Ther       Date:  2008-08       Impact factor: 6.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.